Published in Acta Psychiatr Scand on August 01, 2000
Olanzapine-associated leukopenia and thrombocytopenia managed with lithium in a patient who developed leukopenia with clozapine in the past: a case report. Prim Care Companion CNS Disord (2012) 0.87
Olanzapine-Induced Neutropenia. Ment Illn (2015) 0.75
Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry (2001) 4.70
Brain activation and hypothalamic functional connectivity during human non-rapid eye movement sleep: an EEG/fMRI study. Brain (2005) 2.07
Circulatory and respiratory complications of carbon dioxide insufflation. Dig Surg (2004) 2.06
Increased body-mass index in patients with narcolepsy. Lancet (2000) 1.78
T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol (1993) 1.74
Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy. Sleep Med (2011) 1.50
Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry. J Virol (1997) 1.49
[Findings in a high-risk group following asbestos exposure. Benefit of ENT examinations in patients with long-term exposure to asbestos]. HNO (2002) 1.39
Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry (2006) 1.38
Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res (1999) 1.33
Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J Exp Med (1994) 1.33
Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep (2000) 1.30
Illness, cytokines, and depression. Ann N Y Acad Sci (2000) 1.27
Dose-dependent effects of endotoxin on human sleep. Am J Physiol Regul Integr Comp Physiol (2000) 1.26
Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1. Clin Ther (1996) 1.21
Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology (2001) 1.19
Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology (2001) 1.16
[Prevention, diagnosis, therapy, and follow-up of lung cancer]. Pneumologie (2010) 1.14
EFNS guidelines on management of narcolepsy. Eur J Neurol (2006) 1.13
Depression, comorbidities and the TNF-alpha system. Eur Psychiatry (2008) 1.12
[Airway management in pediatric anesthesia]. Anaesthesist (2006) 1.11
Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry (2002) 1.10
Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients. Neuropsychopharmacology (1998) 1.07
Altered cytokine production and accessory cell function after HIV-1 infection. J Immunol (1996) 1.06
Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie (2010) 1.06
Effects of antipsychotic drugs on cytokine networks. J Psychiatr Res (2001) 1.02
L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep (1995) 1.01
Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry (1999) 1.01
Sleep in schizophrenia: a polysomnographic study on drug-naive patients. Neuropsychopharmacology (1997) 0.98
Pneumoconiosis and emphysema in construction workers: results of HRCT and lung function findings. Occup Environ Med (2011) 0.98
Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol (1999) 0.97
Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J Clin Psychopharmacol (1996) 0.96
Nocturnal plasma levels of cytokines in healthy men. Eur Arch Psychiatry Clin Neurosci (1992) 0.96
Reduced leptin levels in human narcolepsy. Neuroendocrinology (2000) 0.95
Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine. Neuropsychopharmacology (2000) 0.94
[The role of 3-D imaging and computer-based postprocessing for surgery of the liver and pancreas]. Rofo (2005) 0.93
Chronic insomnia: clinical and research challenges--an agenda. Pharmacopsychiatry (2010) 0.92
[Health effects of particulate matter exposure: current scientific knowledge]. Pneumologie (2009) 0.91
[Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version]. Pneumologie (2011) 0.91
Automatic detection of periodic leg movements (PLM) J Sleep Res (1996) 0.90
In vitro cytokine secretion in individuals with schizophrenia: results, confounding factors, and implications for further research. Brain Behav Immun (2001) 0.89
Comminuted fractures of the proximal ulna--Preliminary results with an anatomically preshaped locking compression plate (LCP) system. Injury (2010) 0.88
Ghrelin and eating disturbances in psychiatric disorders. Neuropsychobiology (2008) 0.88
Mediators of inflammation and their interaction with sleep: relevance for chronic fatigue syndrome and related conditions. Ann N Y Acad Sci (2001) 0.88
Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. Mol Psychiatry (2010) 0.87
Endotoxin-induced changes in sleep and sleepiness during the day. Psychoneuroendocrinology (1998) 0.87
Effect of coadministration of clozapine and fluvoxamine versus clozapine monotherapy on blood cell counts, plasma levels of cytokines and body weight. Psychopharmacology (Berl) (2000) 0.87
Levels of 8-hydroxy-2'-deoxyguanosine in DNA of white blood cells from workers highly exposed to asbestos in Germany. Mutat Res (2000) 0.87
Effects of granulocyte colony-stimulating factor on night sleep in humans. Am J Physiol (1999) 0.86
The Baumann procedure to correct equinus gait in children with diplegic cerebral palsy: long-term results. J Bone Joint Surg Br (2012) 0.86
Dose-dependence of bacterial lipopolysaccharide (LPS) effects on peak response and time course of the immune-endocrine host response in humans. Inflamm Res (1999) 0.85
In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls. Neurology (1998) 0.85
Effects of an intravenous catheter on the local production of cytokines and soluble cytokine receptors in healthy men. Cytokine (2000) 0.84
Endotoxin-induced changes in food consumption in healthy volunteers are associated with TNF-alpha and IL-6 secretion. Psychoneuroendocrinology (2002) 0.84
Effects of sleep on endotoxin-induced host responses in healthy men. Psychosom Med (2001) 0.84
Fabrication of silicon nanowire arrays by near-field laser ablation and metal-assisted chemical etching. Nanotechnology (2016) 0.84
A method for the quantification of biomarkers of exposure to acrylonitrile and 1,3-butadiene in human urine by column-switching liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem (2008) 0.84
Analysis of quality and feasibility of an objective structured clinical examination (OSCE) in preclinical dental education. Eur J Dent Educ (2011) 0.84
Sleep during clozapine-induced fever in a schizophrenic patient. Biol Psychiatry (1995) 0.83
Effects of clozapine on sleep: a longitudinal study. Biol Psychiatry (1997) 0.83
Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos. Arch Toxicol (2010) 0.83
A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiatry (2000) 0.83
Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol. Am J Psychiatry (1997) 0.82
The influence of clozapine treatment on plasma granulocyte colony-stimulating (G-CSF) levels. Pharmacopsychiatry (1997) 0.82
Obstructive sleep apnea syndrome induced by clonazepam in a narcoleptic patient with REM-sleep-behavior disorder. J Sleep Res (1999) 0.82
Selection of reference films based on reliability assessment of a classification of high-resolution computed tomography for pneumoconioses. Int Arch Occup Environ Health (2006) 0.82
Glucose tolerance in depressed inpatients, under treatment with mirtazapine and in healthy controls. Exp Clin Endocrinol Diabetes (2009) 0.82